PCI Pharma creates new Clinical Center of Excellence in Germany
Biopharmaceutical global outsourcing solutions provider PCI Pharma Services has expanded its global clinical footprint with the creation of a new…
Biopharmaceutical global outsourcing solutions provider PCI Pharma Services has expanded its global clinical footprint with the creation of a new…
IQVIA has entered a strategic alliance with LMC Manna Research to launch its first Prime Site for clinical investigation in…
Longboat Clinical has launched Patient CONNECT, a unique solution to ease the process of patient recruitment into clinical trials. The Patient CONNECT approach provides much-in-demand…
I’ve generally had very strong relationships with contract research organizations (CROs), but when I started to write this article, it was the first time that…
The Chinese government has announced plans that will allow drug or medical device manufacturers to apply for approval in the…
It has been estimated that there are roughly 800 cancer treatments currently undergoing clinical trials or awaiting FDA approval. The…
Among its most recent regulatory policy notices, the U.S. Food and Drug Administration issued a final guidance document for the…
A universal truism across all commerce is that automation can be an extremely powerful tool, however, if not designed, configured…
We all love trends; fashion trends, music trends, twitter trends, you name it. In clinical trials it is no different –…
Lucy Tanner: What do you see as the biggest difficulty within outsourcing clinical trials at the moment?Industry Expert: Well, the…
When it comes to clinical trial submission, one of the most significant standards is the Analysis Data Model (ADaM), as…
Small animal optical imaging provides oncology researchers with the ability to perform non-invasive longitudinal monitoring of disease progression, detection of…
GEMTESA® (vibegron) is the first new oral medication indicated for the treatment of overactive bladder (OAB) with signs of urge…
OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials…